Clinical Trial Update: YF476 and Type I Gastric Carcinoids [Phase 2]

View source ↗

Summary

A Phase 2 trial update for YF476 evaluating effects on Type I Gastric Carcinoids in patients with Chronic Atrophic Gastritis and Hypergastrinaemia (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Gastritis
• Hypergastrinaemia
• Type Gastric Carcinoids

Drugs mentioned

• YF476

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: Chronic Atrophic Gastritis, Hypergastrinaemia | Phase 2 | Status: COMPLETED